Literature DB >> 19539739

Factors influencing the efficacy of round window dexamethasone protection of residual hearing post-cochlear implant surgery.

Andrew Chang1, Hayden Eastwood, David Sly, David James, Rachael Richardson, Stephen O'Leary.   

Abstract

AIM: To protect hearing in an experimental model of cochlear implantation by the application of dexamethasone to the round window prior to surgery. The present study examined the dosage and timing relationships required to optimise the hearing protection.
METHODS: Dexamethasone or saline (control) was absorbed into a pledget of the carboxymethylcellulose and hyaluronic acid and applied to the round window of the guinea pig prior to cochlear implantation. The treatment groups were 2% w/v dexamethasone for 30, 60 and 120min; 20% dexamethasone applied for 30min. Auditory sensitivity was determined pre-operatively, and at 1 week after surgery, with pure-tone auditory brainstem response audiometry (2-32kHz). Cochlear implantation was performed via a cochleostomy drilled into the basal turn of the cochlea, into which a miniature cochlear implant dummy electrode was inserted using soft-surgery techniques.
RESULTS: ABR thresholds were elevated after cochlear implantation, maximally at 32kHz and to a lesser extent at lower frequencies. Thresholds were less elevated after dexamethasone treatment, and the hearing protection improved when 2% dexamethasone was applied to the round window for longer periods of time prior to implantation. The time that dexamethasone need be applied to achieve hearing protection could be reduced by increasing the concentration of steroid, with a 20% application for 30min achieving similar levels of protection to a 60min application of 2% dexamethasone.
CONCLUSIONS: Hearing protection is improved by increasing the time that dexamethasone is applied to the round window prior to cochlear implantation, and the waiting time can be reduced by increasing the steroid concentration. These results suggest that the diffusion dexamethasone through the cochlea is the prime determinant of the extent of hearing protection.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19539739     DOI: 10.1016/j.heares.2009.05.010

Source DB:  PubMed          Journal:  Hear Res        ISSN: 0378-5955            Impact factor:   3.208


  18 in total

1.  Deep round window insertion versus standard approach in cochlear implant surgery.

Authors:  Karl Fredrik Nordfalk; Kjell Rasmussen; Marie Bunne; Greg Eigner Jablonski
Journal:  Eur Arch Otorhinolaryngol       Date:  2014-12-31       Impact factor: 2.503

2.  Systemic immunity influences hearing preservation in cochlear implantation.

Authors:  Melanie Souter; Hayden Eastwood; Paul Marovic; Gordana Kel; Sarin Wongprasartsuk; Allen F Ryan; Stephen John O'Leary
Journal:  Otol Neurotol       Date:  2012-06       Impact factor: 2.311

3.  Dexamethasone retrodialysis attenuates microglial response to implanted probes in vivo.

Authors:  Takashi D Y Kozai; Andrea S Jaquins-Gerstl; Alberto L Vazquez; Adrian C Michael; X Tracy Cui
Journal:  Biomaterials       Date:  2016-02-10       Impact factor: 12.479

4.  Direct entry of gadolinium into the vestibule following intratympanic applications in Guinea pigs and the influence of cochlear implantation.

Authors:  E B King; A N Salt; H T Eastwood; S J O'Leary
Journal:  J Assoc Res Otolaryngol       Date:  2011-07-19

5.  Influence of cochleostomy and cochlear implant insertion on drug gradients following intratympanic application in Guinea pigs.

Authors:  E B King; J J Hartsock; S J O'Leary; A N Salt
Journal:  Audiol Neurootol       Date:  2013-09-05       Impact factor: 1.854

Review 6.  Corticosteroid therapy for hearing and balance disorders.

Authors:  Dennis R Trune; Barbara Canlon
Journal:  Anat Rec (Hoboken)       Date:  2012-10-08       Impact factor: 2.064

7.  Effect of a liposomal hyaluronic acid gel loaded with dexamethasone in a guinea pig model after manual or motorized cochlear implantation.

Authors:  Elisabeth Mamelle; Naila El Kechai; Benjamin Granger; Olivier Sterkers; Amélie Bochot; Florence Agnely; Evelyne Ferrary; Yann Nguyen
Journal:  Eur Arch Otorhinolaryngol       Date:  2016-10-06       Impact factor: 2.503

Review 8.  New molecular therapies for the treatment of hearing loss.

Authors:  Yutian Ma; Andrew K Wise; Robert K Shepherd; Rachael T Richardson
Journal:  Pharmacol Ther       Date:  2019-05-08       Impact factor: 12.310

9.  Effects of localized neurotrophin gene expression on spiral ganglion neuron resprouting in the deafened cochlea.

Authors:  Andrew K Wise; Clifford R Hume; Brianna O Flynn; Yogesh S Jeelall; Courtney L Suhr; Beatrice E Sgro; Stephen J O'Leary; Robert K Shepherd; Rachael T Richardson
Journal:  Mol Ther       Date:  2010-03-09       Impact factor: 11.454

10.  Effects of intraoperatively applied glucocorticoid hydrogels on residual hearing and foreign body reaction in a guinea pig model of cochlear implantation.

Authors:  Clemens Honeder; Lukas David Landegger; Elisabeth Engleder; Franz Gabor; Roberto Plasenzotti; Hanns Plenk; Alexandra Kaider; Lena Hirtler; Wolfgang Gstoettner; Christoph Arnoldner
Journal:  Acta Otolaryngol       Date:  2015-02-26       Impact factor: 1.494

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.